trimeprazine has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Trimeprazine: A phenothiazine derivative that is used as an antipruritic.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) is a risk factor for progression of steatohepatitis, liver cirrhosis, and liver cancer." | 1.56 | Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment. ( Chun, YS; Jeong, DW; Ju, UI; Kim, JB; Park, JB; Park, JW; Seo, J; Suh, KS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ju, UI | 1 |
| Jeong, DW | 1 |
| Seo, J | 1 |
| Park, JB | 1 |
| Park, JW | 1 |
| Suh, KS | 1 |
| Kim, JB | 1 |
| Chun, YS | 1 |
1 other study available for trimeprazine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment.
Topics: Humans; NEDD8 Protein; Non-alcoholic Fatty Liver Disease; Risk Factors; Sterol Regulatory Element Bi | 2020 |